Trial Profile
A clinical study on safety and efficacy of sorafenib as maintenance chemotherapy after percutaneous isolated hepatic perfusion chemotherapy (PIHP) for advanced hepatocellular carcinoma
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 19 Feb 2018
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 17 Feb 2018 Status changed from recruiting to completed.
- 25 Sep 2012 New trial record